Alexandra DeVries, Alec Lawson, Aysham Chaudry, Wilhelmina Lam, Mark S Nestor
Journal: The Journal of clinical and aesthetic dermatology 2026;19(8):57-66
PMID: 42877871
BACKGROUND
Curcumin (CUR), the principal polyphenol in Curcuma longa, has gained increasing interest in dermatology because of its anti-oxidant, anti-inflammatory, antimicrobial, photoprotective, and regenerative properties. Despite versatile biological activity, its clinical use has been limited by poor bioavailability and significant product variability across formulations.
METHODS
A targeted PubMed search was conducted using a combination of the following keywords: "curcumin," "turmeric," and "dermatology." Only articles in English and relevant to this review were included. Additional articles were included through citation tracking and the authors' clinical expertise.
RESULTS
The search yielded 375 results, and 94 articles and 2 webpages were included based on the inclusion and exclusion criteria.
DISCUSSION
CUR modulates multiple intracellular pathways, resulting in reduced pro-inflammatory cytokine expression, improved oxidative balance, and enhanced tissue repair. Despite an extremely favorable safety profile, the clinical use of CUR remains limited by poor bioavailability; however, newer formulations, including US Food and Drug Administration-recognized medical foods, have substantially improved absorption and product consistency. Clinically, CUR has shown immunomodulatory and anti-inflammatory effects applicable to cutaneous conditions including psoriasis, atopic dermatitis, and photodamage and has exhibited antimicrobial activity in acne. Aesthetically, CUR reduces melanogenesis and provides firming effects by limiting oxidative stress and matrix metalloproteinase activity. Regeneratively, it modulates key longevity-associated pathways involved in cellular senescence, wound healing, and anti-aging.
CONCLUSION
CUR represents a safe and multifaceted agent with clinical, aesthetic, and regenerative dermatologic benefits. Emerging medical food formulations offer improved bioavailability and product consistency, though larger clinical trials are needed to define optimal dosing and long-term efficacy.
Copyright © 2026. Matrix Medical Communications. All rights reserved.
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.